Our Research


At Houston Methodist, fostering innovations with the potential for clinical application is at the very heart of what we do. Our interdisciplinary teams of clinicians and researchers are committed to streamlining the process of translating discoveries into treatments and cures for our patients.


Learn more about how we are delivering on our commitment to leading medicine from the earliest phase of discovery in a lab to the testing new drugs or therapies in clinical trials.


Our Annual Report

Neuroscientists find molecular clue in als suggesting potential new drug target

Houston Methodist researchers led by Muralidhar Hegde, PhD, and Haibo Wang, PhD, have discovered a repair defect in nerve cells that send messages to the brain, opening the door to a possible therapy for preventing or slowing down ALS. Learn more>


Scientists create Nanodevice to deliver immunotherapy without side effects

Houston Methodist scientists led by Alessandro Grattoni, PhD, have developed a nanodevice to deliver immunotherapy without side effects to treat triple-negative breast cancer. Learn More>


RNA Therapy Reverses Effects of Aging in Progeria Cells

Cooke Feature Image

Houston Methodist scientists led by John Cooke, MD, PhD used telomerase mRNA technology to reverse senescence, rejuvenating aging human cells. Learn more.

Smartphone App Improves Health of Breast Cancer Survivors

smartphone app for breast cancer

A Houston Methodist smartphone app developed by Stephen T.C. Wong, PhD, PE and his team shows promising results for breast cancer survivor health after treatment. Learn more>

Latest News
Wednesday, September 4, 2019 Research shows OB-GYNs hesitate to talk about fertility
A new study shows that many OB-GYNs are uncomfortable counseling their patients on fertility at a time when more women are delaying pregnancy and needing their doctors to be more vigilant about this education.   “We found that most OB-GYNs don’t bring up fertility with every patient, often because...
Read more
Monday, July 22, 2019 Scientists develop promising drug for treating ovarian and pancreatic cancers
Known as two of the most lethal cancers, ovarian and pancreatic cancer are often called silent killers since they rarely have early symptoms. As a result, they frequently go undetected until they’re too late to effectively treat.   Cancer scientists at Houston Methodist and The University of Texas...
Read more
Live Chat Available